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lation of macrophages that are involved in immune-mediatedEfficacy of galectins in the amelioration of nephrotoxic serum
glomerular diseases.nephritis in Wistar Kyoto rats.
Background. Galectins are characterized by specific affinity
for b-galactoside sugars, and they play a role in diverse biologi-
cal processes, including cell adhesion, cell proliferation, and
Mammalian lectins are carbohydrate-binding proteinsapoptosis. Galectin-1, -3, and -9 have been implicated in modu-
that have affinity for specific oligosaccharides, and theylating the immune response.
Methods. Nephrotoxic serum nephritis, which is character- have been classified into four groups: C-type lectins,
ized by crescent formation and glomerular influx of CD81 P-type lectins, pentraxins, and galectins; the latter are
cells into glomerular capillaries, was induced in Wistar Kyoto formerly known as soluble-type (S-type or S-Lac) lectins(WKY) rats by injecting rabbit antiglomerular basement mem-
[1, 2]. Since the polysaccharide chains constitute an inte-brane serum. Following induction, the rats were treated either
gral component of many plasmalemmal and of the extra-with phosphate-buffered saline or dexamethasone, galectin-1,
galectin-3, or galectin-9 on alternate days and were sacrificed cellular matrix (ECM) proteins, it is conceivable that by
at day 14. At day 8, splenic lymphocytes were isolated and virtue of the interaction between lectins and their puta-
employed for terminal deoxytransferase-mediated uridine tri-
tive ligands they mediate a wide variety of biologicalphosphate nick end-labeling (TUNEL) assay to assess the de-
process [3]. Among the lectins, the role of Ca11-depen-gree of apoptosis, and the kidneys were utilized to determine
the extent of influx of CD41 and CD81 cells and glomerular dent (C-type) mammalian lectins has been well docu-
damage. mented in various biological processes. For instance, the
Results. Dexamethasone induced a marked apoptosis of adhesion of leukocytes to the activated endothelial cellssplenic CD41 and CD81 cells, and it inhibited the production
has been shown to be mediated by selectins and theirof anti-rabbit IgG and the influx of CD81 cells and macro-
ligands, that is, sialylated and fucosylated oligosaccha-phages into the renal glomeruli. Crescent formation and excre-
tion of urinary proteins were also reduced. Galectin-9 failed rides, such as sialyl-Lewisx and sialyl-Lewisa [4].
to induce apoptosis in the CD41 cells; however, it induced Galectins, a subcategory of lectins, are characterized
apoptosis in the CD81 cells and inhibited the infiltration of
by specific affinity for b-galactoside sugars, and they haveCD81 cells. Although galectin-1 and -3 did not induce the
conserved amino acid sequence of their carbohydrate-apoptosis in the T cells, they inhibited the accumulation of
macrophages in the renal glomeruli. Like dexamethasone, the binding domains. To date, at least 10 family members of
galectins also reduced the crescentic formation, proliferation galectins have been identified and cloned [3, 5, 6]. Their
of glomerular cells, and excretion of urinary proteins. structural analysis indicates the presence of homodimericConclusions. Galectin-9 selectively induces apoptosis of the
carbohydrate-binding domains in galectin-1 (G1), -2activated CD81 cells, while the macrophage influx into the
(G2), -5 (G5), -7 (G7), and -10 (G10) and a single poly-kidney is modulated by all three galectins. This finding raises
an interesting possibility for the utility of galectins in the modu- peptide chain with two carbohydrate domains in galectin-4
(G4), -6 (G6), -8 (G8), and -9 (G9; Fig. 1). The galectin-3
(G3) has a unique structure with a single carbohydrate-Key words: dexamethasone, crescentic glomerulonephritis, apoptosis,
CD81 cells, macrophages, immune response. binding domain and a short N-terminal hnRNP-like do-
main. Despite their homologous biochemical structures
Received for publication July 20, 1999
and similarity in ligand recognition, each seems to beand in revised form April 27, 2000
Accepted for publication May 22, 2000 involved in distinct but diverse physiological and patho-
logical processes. They have been shown to be involvedÓ 2000 by the International Society of Nephrology
1941
Tsuchiyama et al: Galectins in NTS nephritis1942
Fig. 1. Schematic drawing of galectin gene
family. Galectin-1 (G1) is a prototype of galec-
tin family consisting of a homodimer of ap-
proximately 14 kD subunits. Each subunit has
a specific binding domain for b-galactoside.
G3, the chimeric type, has two distinct do-
mains: the N-terminal hnRNP-like domain
and the C-terminal carbohydrate-binding do-
main. G9, a tandem repeat type, has two car-
bohydrate-binding domains connected by a
link peptide. The sequence of two domains is
not identical, and they share approximately
38% homology at the amino acid level [5].
in organogenesis [7], oncogenesis [8, 9], aggregation, ad- (WKY) rats was assessed in this investigation. NTS ne-
phritis in WKY rats is characterized by crescentic glo-hesion, migration and proliferation of the cells [3], bind-
ing with advanced glycation end products (AGEs) [10], merulonephritis, production of antibodies against the
injected heterologous serum IgG, deposition of immuno-mRNA splicing [11], bacterial colonization [12], athero-
globulins and complements in the glomeruli, and infil-sclerosis [13], and apoptosis and in the modulation of
tration of CD81 cells and macrophages into the renalthe immune response [3]. This diversity in their functions
capillaries [19, 20]. Various cell types of the immunoreg-is conceivably related to the variation in the sugar moie-
ulatory system, including B cells, T cells, and macro-ties of the putative ligands in a given cell and to their
phages, are involved in the pathobiology of NTS nephri-widespread distribution in various tissues. In the latter
tis in WKY rats. In this report, we describe the efficacyinstance, the galectins may be expressed in the nucleus
of galectins in NTS nephritis in WKY rats and theiror cytoplasm, on the cell surface, and within ECM [1–3].
pharmaceutical target cell types.Among the various functions, their role in the induction
of apoptosis and in the modulation of the immune re-
sponse has been well documented [3]. G1 ameliorates the
METHODS
severity of certain experimental autoimmune diseases
Animals and preparation of rabbit nephrotoxic serum[14, 15] and induces apoptosis of the activated peripheral
human T cells [16] and isolated human thymocytes [17]. Four-week-old female WKY rats, weighing approxi-
mately 100 g, were purchased from Charles River JapanG9, which is highly expressed in thymus, also induces
apoptosis of the thymocytes [6]. In contrast, G3 acts as a (Atsugi, Kanagawa, Japan) and were used for the isola-
tion of glomerular basement membranes (GBMs), whichsafeguard for T cells and prevents them from undergoing
apoptosis by forming heterodimers with bcl-2 in the cyto- were used as an antigen for the induction of NTS nephri-
tis. WKY kidneys were perfused with physiologic saline.plasm [18].
In view of these studies, recombinant soluble galectins They were then harvested, homogenized, and glomeruli
isolated. An emulsion of equal volume of the homogenatewere generated, and their efficacy in the amelioration
of nephrotoxic serum (NTS) nephritis of Wistar Kyoto and the Freund’s complete adjuvant (Difco Laboratories,
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Detroit, MI, USA) was prepared and injected subcutane- with PBS containing 1 mmol/L DTT, DEX, G1, G3, and
G9. The 10 groups (N 5 4 each) were sacrificed at dayously into rabbits twice a month for two months. Three
weeks after the last injection, the rabbits were bled, and 8, and their tissues were used for immunoperoxidase
staining of CD41 and CD81 cells and fluorescence-acti-the antisera were isolated. The antiserum was decomple-
mented for 30 minutes at 568C and adsorbed with freshly vated cell sorter (FACS) analysis. Since the peak of the
infiltration of CD81 cells was observed at day 3 andharvested rat red blood cells, and finally, it was used for
the induction of nephritis of WKY rats. gradually declined up to day 11, the animals were sacri-
ficed at day 8.
Preparation of mouse recombinant protein of
galectins-1, -3 and -9 Light microscopy
Tissues were fixed in 10% formaldehyde and embed-Recombinant galectins (G1, G3, and G9) were prepared
by using pTrcHis2 vector (Invitrogen, San Diego, CA, USA), ded in paraffin, and 3 mm thick sections were prepared.
The sections were stained with periodic acid-Schiff (PAS).as previously described [5, 6]. These recombinant pro-
teins were fusion proteins with C-terminal c-myc epitope The diameter of 50 glomeruli of each animal were mea-
sured, and the number of total glomerular cells and theand (His)6. In brief, the constructs of G1 (pTrcHis2/G1),
G3 (pTrcHis2/G3), and G9 (pTrcHis2/G9) [6] were trans- glomeruli with crescents were counted.
formed into the TOP 10 bacterial host (Invitrogen). A
single transformed bacterial colony was grown in Luria-
Immunofluorescence
Bertani’s broth, and protein synthesis was induced with
Four-mm thick cryostat sections were incubated withthe addition of 1 mmol/L isopropyl-b-D-thiogalactopyr-
FITC-labeled goat anti-rabbit IgG or goat anti-rat IgG,anoside (IPTG). The cell pellets were prepared, and they
goat anti-rat C3, or goat anti-rat fibrinogen (Cappel,were lyzed in Tris-dithiothreitol (Tris-DTT) buffer (20
Costa Mesa, CA, USA). The staining intensity was semi-mmol/L Tris, pH 7.4, 5 mmol/L ethylenediaminetetraace-
quantitatively graded as follows: (2) 5 no staining; (1) 5tic acid (EDTA), 150 mmol/L sodium chloride, 1 mmol/L
weak staining; (11) 5 moderate staining; (111) 5DTT), containing 1% Triton X-100, 10 mmol/L benzami-
strong staining; (1111) 5 very strong staining. In addi-dine, 10 mmol/L e-amino-n-caproic acid, and 2 mmol/L
tion, the 2 mm thick serial cryostat sections were prepared.phenylmethanesulfonyl fluoride. The lysates were centri-
For the staining for the proliferation marker Ki-67, thefuged at 20,000 3 g at 48C for 30 minutes. The superna-
sections were fixed with acetone on ice and boiled for 10tants were applied to 10 mL lactosyl-Sepharose column
minutes. They were incubated with mouse monoclonal(Sigma, St. Louis, MO, USA). The unbound protein was
antibody against Ki-67 (Dako, Glostrup, Denmark) forwashed, and fusion proteins were eluted with Tris-DTT
two hours. The adjacent sections were incubated withbuffer containing 200 mmol/L lactose. The eluted fractions
mouse monoclonal anti-rat monocytes/macrophages (ED1;were collected, dialyzed against phosphate-buffered sa-
Serotec, Oxford, UK) for one hour and mouse mono-line (PBS) containing 1 mmol/L DTT, and kept in 2708C
clonal anti–a-smooth muscle actin (a-SMA; Sigma) forfor further use. The samples were subjected to 12.5%
one hour. They were finally incubated with FITC-conju-sodium dodecyl sulfate-polyacrylamide gel electrophore-
gated anti-mouse IgG (Cappel) for 30 minutes. The num-sis (SDS-PAGE), and all galectins gave single band with
bers of Ki-67, ED1, and a-SMA–positive cells per glo-proper molecular weight [5].
merular cross section were counted. Twenty glomeruli
Induction of NTS nephritis per rat were examined, and the average number of the
positive cells in glomeruli was calculated.Nephrotoxic serum was injected intraperitoneally (2
mL/kg weight) into 40 WKY rats at day 1. WKY rats
Immunoperoxidase stainingwere then treated either with PBS containing 1 mmol/L
The degree of influx of leukocytes into the glomeruliDTT (N 5 8) or dexamethasone (DEX; 0.17 mg/kg
was assessed by using immunoperoxidase ABC kit (Vec-weight, N 5 8), G1 (1 mg/kg weight, N 5 8), G3 (1 mg/kg
tor Laboratories, Burlingame, CA, USA), as describedweight, N 5 8) or G9 (1 mg/kg weight, N 5 8) on alternate
previously [21]. Briefly, cryostat sections were first incu-days for two weeks. Urine collection was carried out,
bated for 60 minutes with mouse monoclonal antibodiesand 24-hour urinary protein excretion was measured.
against rat leukocytes (OX1), or rat monocytes/macro-The rats were sacrificed at day 14, and their kidney tissues
phages (ED1), rat CD4, or rat CD8 (Serotec Ltd.). Thewere processed for light and immunofluorescent micros-
sections were then incubated with biotinylated horsecopy and for in situ terminal deoxytransferase (TdT)-
anti-mouse IgG for 30 minutes at 228C, followed by treat-mediated uridine triphosphate (dUTP) nick end labeling
ment with 3,3-diamino-benzidine and hydrogen perox-(TUNEL) reaction to assess the extent of apoptosis. In
ide. The cells with brownish reaction product were enu-separate experiments, the additional 20 NTS nephritis
and 20 normal WKY rats were prepared and treated merated, and the number of OX1, ED1, CD4, and CD8
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positive cells per glomerular cross section were counted. and TdT (In Situ Cell Death Detection Kit). After incu-
bation in a humidified chamber in dark for 60 minutesTwenty glomeruli per rat were examined, and the aver-
age number of positive cells in glomeruli was calculated. at 378C, cells were washed twice in PBS and adjusted to
a final volume of 500 mL. Finally, they were analyzed
In situ TUNEL assay in renal tissues by two-color flow cytometry (FACS Caribur 3A; Becton
Dickinson, Mountain View, CA, USA), and the percent-Apoptotic cells in renal tissues were visualized by in
situ TUNEL method using FITC-dUPT (In Situ Cell age of apoptotic cells in the subpopulation of T cells was
determined.Death Detection Kit; Boehringer Mannheim, Mannheim,
Germany). Four micrometer thick cryostat sections of
Distribution of exogenously injected galectin-9 in thethe kidney were prepared and fixed with 4% paraformal-
kidney tissuedehyde for 20 minutes at 228C. Sections were then per-
meabilized with 0.1% Triton X-100 in 0.1% sodium ci- Galectin-9 (1 mg/kg weight) was injected into normal
WKY rats, and they were sacrificed after four hours. Thetrate for two minutes on ice. The sections were then
immersed in the TUNEL reaction mixture and incubated cryostat sections of kidneys were prepared, and they
were incubated with anti-myc antibody (Invitrogen).in a humidified chamber for 60 minutes in dark. Fifty
glomeruli per in each WKY rats were examined, and They were then stained with rhodamine-labeled horse
anti-mouse IgG (Vector Laboratories). They were furtherapoptotic cells in glomeruli were counted.
double stained with rabbit anti-G9 antibody [5, 6] and
Enzyme-linked immunosorbent assays for circulating FITC-labeled donkey anti-rabbit IgG (Chemicon). Sec-
anti-rabbit IgG antibody ondary antibodies were already absorbed against serum
protein, which minimized the cross reactivity to IgG ofThe titer of anti-rabbit IgG in rat serum was deter-
mined by enzyme-linked immunosorbent (ELISA). A other species. Only exogenously injected fusion protein
carrying the C-terminal myc was detected by anti-myc96-well plate was used, and each well was incubated
with 50 mL of normal rabbit IgG (10 mg/m; Chemicon, antibody, since the intrinsic G9 lacked the myc epitope.
Temecula, CA, USA) overnight at 228C. The next day,
Statistical analysis50 mL of 1:40-diluted serum (collected from rats at day
14) was added to the wells, and incubation was carried for The data were expressed as mean 6 SD. Significance
of difference (P values of less than 0.05) was determinedtwo hours. This was followed by the addition of alkaline
phosphatase-labeled rabbit anti-rat IgG (Southern Bio- by analysis of variance (ANOVA). Fischer’s analysis was
performed.technology Associates, Birmingham, AL, USA) at a dilu-
tion of 1:2000 and incubation for two hours. Finally, a
p-nitrophenyl phosphate substrate solution (Sigma) was
RESULTS
added and incubated for one hour, and absorbance read-
Urinary protein excretionsings at 405 nm, using the Microplate Reader (Japan Bio-
Rad, Tokyo, Japan), were recorded. The control rats injected with normal rabbit serum
showed minimal 24-hour urinary protein excretion (1.9 6
FACS analysis 0.4 mg/day). The rats injected with NTS revealed mini-
mal proteinuria during the first week, but in the secondMononuclear cells, isolated from spleen, were subjected
to CD4 or CD8 staining and TUNEL reaction. First, week, the urinary protein excretion progressively increased
and was 35.8 6 7.1 mg/day at day 14. Daily urinaryspleens were homogenized and suspended in RPMI-1640
(GIBCO BRL, Grand Island, NY, USA). They were over- protein excretions were significantly suppressed in rats
treated with DEX or galectins. The DEX treatment dras-laid onto endotoxin-free Ficoll-Plaque (Pharmacia Bio-
tech, Uppsala, Sweden) and centrifuged at 2000 r.p.m. for tically reduced the urinary protein excretion (2.3 6 0.4
mg/day). Similarly, the treatment with G1, G3, and G920 minutes. Mononuclear cells were collected and washed
two times in PBS at 48C and adjusted to 2 3 107 cells/mL. resulted in a significant reduction of proteinuria, and
respective values for 24-hour excretions were 5.6 6 1.8,Cells were then stained with phycoerythrin-conjugated
anti-rat CD4 antibody (Serotec Ltd.) or phycoerythrin- 11.6 6 2.3, 9.5 6 4.5 mg/day (Fig. 2).
conjugated anti-rat CD8 antibody (Antigenix America
Light microscopyInc., Franklin Square, NY, USA) and fixed with 100 mL
of freshly prepared paraformaldehyde solution (4% in Light microscopic examination of rat kidneys with
NTS nephritis revealed hypertrophy and hypercellularityPBS, pH 7.4). Fixative was removed after centrifugation,
and the cells were permeabilized with 0.1% Triton X- of most of the glomeruli (Table 1). About 56% of the
glomeruli had cellular crescents (Table 1 and Fig. 3d),100 in 0.1% sodium citrate for two minutes on ice. Cells
were rewashed twice with PBS and suspended in 50 mL of and severe necrotizing lesions were also observed in the
glomeruli. By immunofluorescence microscopy, the glo-TUNEL reaction mixture containing fluorescein-dUTP
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Fig. 2. Urinary protein excretion in Wistar
Kyoto (WKY) rats with nephrotoxic serum
(NTS) nephritis. Daily urinary protein excre-
tions at day 14 were significantly suppressed
by treatment of galectins (A) G1, (B) G3, or
(C) G9, and (D) dexamethasone (DEX). DEX
treatment reduced the urinary protein excre-
tion (2.3 6 0.4 mg/day). The treatment of G1,
G3, and G9 yielded a similar antiproteinuric
effect (5.6 6 1.8, 11.6 6 2.3, and 9.5 6 4.5
mg/day, respectively). Symbols are: (j) PBS,
WKY rats with NTS, and PBS containing 1
mmol/L DTT; (d) G1, G3 and G9, NTS ne-
phritis WKY rats receiving G1, G3, and G9
in panels A-C, respectively; (d) DEX, NTS
nephritis WKY rats treated with DEX (D);
*P , 0.01 vs. PBS.
Table 1. Glomerular hypertrophy and proliferation of various In all control and experimental groups, linear rabbit
groups of Wistar Kyoto (WKY) rats
IgG in glomeruli was not altered (not shown).
Diameter of Total number of Cellular
glomeruli glomerular cells crescents Quantitative study of infiltrating cells and proliferation
lm /glomerulus % in the glomeruli
PBS 206.3640.2 167632 56610
Immmunoperoxidase reaction was used to detect theG1 143.8632.1 61624a 562a
G3 150.0634.8 72618a 863a presence of inflammatory cells in the glomerulus. In rats
G9 146.6636.2 66623a 562a with NTS nephritis, at day 8, the number of CD81 and
DEX 131.3620.4 52615a 368a
CD41 cells was 3.5 6 0.8/glomerulus and 0.9 6 0.2/glo-
The total number of nuclei in glomerulus is indicated as mean 6 SD; the percent- merulus, respectively (Fig. 4A). At day 14, leukocyteage of crescentic formation is also shown as mean 6 SD. Groups are defined as:
PBS, WKY rats with nephrotoxic serum (NTS) and phosphate-buffered saline infiltration into the glomeruli increased dramatically
(PBS) contained 1 mmol/L dithiothreitol (DTT); G1, G3, and G9, NTS nephritis (28.3 6 3.4/glomerulus), and most of the cells were mac-WKY rats received galectin-1, -3 and -9, respectively; DEX, NTS nephritis WKY
rats treated with dexamethasone (DEX). rophages (25.0 6 2.6/glomerulus; Fig. 4B). In the DEX-
a P , 0.001 vs. PBS treated group, the infiltration of CD81 cells decreased
to 0.6 6 0.2/glomerulus and of macrophages to 2.3 6
0.1/glomerulus. G1 and G3 treatment failed to inhibit
the infiltration of CD81 cells; however, they significantlymeruli showed linear and granular capillary deposition
inhibited the infiltration of macrophages into glomeruli.of rat IgG and granular deposits of rat C3 and fibrin
In contrast, G9 treatment suppressed the infiltration of(Fig. 3 a–c and Table 2).
CD81 cells to 1.2 6 0.2/glomerulus.In the DEX-treated group, less than 3% of the glomer-
The proliferation marker, that is, Ki-67, and cell typeuli had crescents, and no significant proliferation of cells
marker, ED1, were examined on the serial sections ofor glomerular hypertrophy was observed (Fig. 3t). Also,
kidney tissues. The immunoreactivity of Ki-67 in thethe deposition of rat IgG, C3, and fibrin in the glomeruli
glomeruli of PBS-treated NTS nephritis rats was seenwas minimal (Fig. q, r, s and Table 2).
on the nuclei, and most of them were also positive forGalectin-treated rats (G1, G3, and G9) showed mor-
ED1, that is, the marker for monocytes/macrophagesphological changes similar to the DEX-treated group
(Fig. 5A, a and b). The ED1- and Ki-67–positive cellsby immunofluorescence and light microscopy. Crescents
were abundant in PBS-treated NTS nephritis rats (24 6were seen in 5 to 8% of the glomeruli, however, the
8 and 22 6 7/glomerulus, respectively), and they werehypercellularity of glomeruli was not observed (Figs. 3
significantly suppressed in G1, G3, G9, and DEX-treatede–t), and the deposition of rat IgG and C3 was not altered
in glomeruli (Table 2). rats. In contrast, the distribution of a-SMA was distinct
Fig. 3. Immunofluorescence and light micrographs of kidney specimens from WKY rats with NTS nephritis. By immunofluorescence microscopy,
the glomeruli of NTS nephritis rats reveal a capillary linear deposition of rat IgG and granular deposition of rat C3 and of fibrin (a–c). By light
microscopy, glomeruli with cellular crescents are seen (d). In the DEX-treated group, the deposition of rat IgG, C3, and fibrin is completely inhibited
(q–s), and the glomeruli show no morphologic abnormality (t). In galectin-treated groups (G1, G3, and G9), the deposition of rat IgG and C3 is
not inhibited in the glomeruli (e, f, i, j, m, and n). However, the deposition of fibrin is notably inhibited (g, k, and o), and also the glomeruli show
minimal proliferation of mesangial cells (h, l, and p). PBS is defined as WKY rats with NTS, and PBS containing 1 mmol/L DTT; G1, G3, and
G9, NTS nephritis WKY rats receiving galectins-1, -3, and -9, respectively; DEX, NTS nephritis WKY rats treated with dexamethasone; bar, 100 mm.
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Table 2. Staining score of immunofluorescence in renal glomeruli Circulating anti-rabbit IgG levels by ELISA
of various groups of WKY rats
Dexamethasone treatment abolished the production of
IgG C3 Fibrinogen anti-rabbit IgG antibody. However, the administration of
PBS (1111) (11) (1111) galectins did not affect the antibody production (Fig. 6).
G1 (111) (11) (2)
G3 (111) (11) (2)
In situ TUNEL assay of kidney tissueG9 (111) (11) (2)
DEX (2) (2) (2) In PBS-treated NTS nephritis rats, few apoptotic cells
The staining intensity was semiquantitatively graded according to the following were seen in the glomeruli at day 14 (Fig. 7A). No in-scale: (2) 5 no staining; (1) 5 weak staining; (11) 5 moderate staining;
(111) 5 strong staining; (1111) 5 very strong staining. Groups are defined crease of apoptotic cells was observed in kidney tissues
in Table 1 footnote. of NTS nephritis rats treated either with DEX or galec-
tins (Fig. 7B).
Apoptosis assay of T cells isolated from spleen
In PBS-treated normal rats, approximately 7% of both
the CD41 cells and CD81 cells, isolated from spleen, un-
derwent spontaneous apoptosis. In DEX-treated normal
rats, the apoptosis was observed in approximately 25%
of the CD41 cells and approximately 28% of the CD81
cells. No significant increase of apoptosis was observed
in the galectin-treated normal rats (Table 3 and Fig. 8).
In NTS-treated rats, approximately 6% of the CD41
cells and approximately 5% of the CD81 cells isolated
from spleen underwent spontaneous apoptosis, and the
ratio of apoptotic cells was similar to that of normal PBS-
treated rats. The DEX treatment increased apoptosis to
approximately 20% for the CD41 cells and approxi-
mately 26% for the CD81 cells, which was similar to that
observed in PBS-treated normal rats. G1 and G3 induced
a basal level of apoptosis (5 to 9%) both in CD41 cells
and CD81 cells; however, G9 induced an accentuated
apoptotic response in CD81 cells (approximately 17%),
while the apoptosis in CD41 cells remained close to
the basal level (,9%). These data indicate that DEX
treatment induced apoptosis in both resting and acti-
vated T cells, while G9 induced a selective apoptotic
response in the activated CD81 splenic T cells in the
Fig. 4. Quantitative analyses of infiltrating cells in the glomeruli of NTS-treated rats.
WKY rats. (A) In NTS nephritis WKY rats, the influx of (h) CD81
cells was noted in the glomeruli, while that of (j) CD41 cells was Distribution of exogenously injected galectins in therelatively less at day 8. (B) At day 14, prominent leukocyte infiltration
kidney tissueinto the glomeruli was observed, and most of them were macrophages.
Symbols are: (j) ED1, (h) OX1. DEX treatment inhibits the infiltration The exogenously injected G9 was detected with anti–of both CD81 cells and macrophages. G1 and G3 treatment failed to
c-myc antibody. Exogenous G9 was distributed on endo-inhibit the infiltration of CD81 cells; however, they significantly inhibited
the infiltration of macrophages into glomeruli. In contrast, G9 treatment thelial cells of glomeruli and peritubular capillaries (Fig.
suppressed the infiltration of CD81 cells and macrophages. Definitions
9, red). Somehow, partial population of endothelial cellsof the groups are in the legend to Figure 3; *P , 0.01 vs. PBS.
of peritubular and glomerular capillaries revealed posi-
tive immunoreactivity. The immunoreactivity of intrinsic
G9 was detected on glomerular cells, and it was distrib-from that of ED1 and Ki-67, and only a part of mesangial
uted on both endothelial and mesangial cells (Fig. 9,cells was positive for a-SMA in PBS-treated NTS nephri-
green) as reported previously [6]. The double-stainingtis rats (Fig. 5A, c). The result indicated that mesangial
method indicated that exogenously injected G9 domi-cells were not actively proliferating, and the accumula-
nantly located glomerular capillary endothelial cells, andtion of the glomerular cells in NTS nephritis was due
the distribution pattern was different from the localiza-to the influx of macrophages into glomeruli and their
proliferation. tion of intrinsic G9.
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Fig. 5. Immunofluorescence micrographs of
kidney specimens and quantitative analysis of
proliferating cells in glomeruli of WKY rats
with NTS nephritis. (A) Immunostaining of
serial sections indicated that Ki-67–positive
cells were seen in the glomeruli of PBS-treated
NTS nephritis rats (B), and most of them were
also positive for ED1 (a), which is the marker
for monocytes/macrophages. In contrast, the
distribution of a-SMA was distinct from that
of ED1 and Ki-67, and only a part of mesangial
cells was positive for a-SMA in PBS-treated
NTS nephritis rats (c). The smooth muscle cells
of small artery was also positive for a-SMA.
(B) The (j) ED1- and (h) Ki-67–positive
cells were abundant in PBS-treated NTS ne-
phritis rats, and they were significantly sup-
pressed in G1, G3, G9, and DEX-treated rats.
(Bar, 100 mm).
DISCUSSION apoptosis of phytohemagglutinin (PHA)-activated pe-
ripheral T cells [16] and of the thymocytes [17]. Such anThe prevalence of specific interactions between lectins
induction by the galectin seems to be specific and isand oligosaccharides expressed on the plasmalemma of
conceivably mediated via its sugar-binding moiety onthe thymus-derived T cells suggests a potential role of
apoptosis-related receptors (death receptors) [22] sincegalectins in the biology of the mammalian immunoregu-
apoptosis can be inhibited by lactose [16, 17]. It is likelylatory system. Among the various galectins, the role of
that G9 as well induces apoptosis of thymocytes by aG1, G3, and G9 has been certainly implicated in various
processes related to the immune response. G1 induces b-galactoside-specific binding pathway [5]. The human
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Table 3. Apoptosis of T-cells isolated from spleen of WKY rats
Normal rats NTS
CD41 CD81 CD41 CD81
PBS 6.861.8 7.062.1 5.761.8 4.862.0
G1 9.162.0 8.962.2 9.162.3 8.661.8
G3 8.161.6 6.461.8 5.962.1 7.061.6
G9 8.661.9 8.462.1 9.261.6 16.862.2a
DEX 24.962.8a 28.362.4a 20.162.6a 25.762.9a
Data are expressed as the percentage of apoptotic cells, mean 6 SD in each
T-cell subpopulation. Groups are defined in Table 1 footnote.
a P , 0.01 vs. PBS
Fig. 6. Circulating antirabbit IgG levels by ELISA. DEX treatment
abolished the production of antirabbit IgG antibody. However, the
administration of galectins did not affect the antibody production. Defini-
tions of the groups are in the legend to Figure 3; *P , 0.01 vs. PBS.
homologue of the latter galectin was isolated by screen-
ing a Hodgkin’s lymphoma cDNA library with a circulat-
ing autoantibody of patients with lymphoma [23], while
the murine homologue was isolated from the embryonic
mouse kidney [5]. Although G9 is widely distributed in
various tissues, it is heavily expressed in lymphatic tis-
sues, especially in thymic epithelial cells [5], thus sug-
gesting a functional relationship between these two ga-
lectins. G1 is a homodimer with carbohydrate-binding
domains, and G9 is a single peptide chain with two carbo-
hydrate-binding domains. By virtue of having two carbo-
hydrate-binding domains, both the galectins, that is, G1
and G9, can cross-link two glycoconjugates on the cell
surface. Whereas G3, which is a monomer that can self-
associate at its N- or C-terminal domain, can mediate
cross-linking of glycoprotein counter-receptor similar to
G1 and G9 [24, 25]. In addition, G3 is also expressed in
the cytoplasm and exerts an anti-apoptotic effect in T
cells. Such an effect may be related to the NWGR motif
in G3 since a similar motif is present in bcl-2, a molecule
that is known to have an anti-apoptotic property [18].
Among the various human glomerular diseases, the
crescentic form of glomerulonephritis has a rapid and
relentless progression of the disease that results in renal
failure unless aggressive immunosuppressive therapy is
instituted [26, 27]. Similar to the human form crescentic
glomerulonephritis, the disease can be induced in WKY
rats by a single injection of anti-GBM antibody [19, 20].
Besides the crescentic change, the glomerular lesions
include the infiltration of CD81 cells and macrophages
into glomeruli [19]. The latter may be due to the CD81
cell-induced up-regulated expression of intercellular ad-
hesion molecule-1 (ICAM-1) in the endothelial cells,
which facilitate the recruitment of macrophages into glo-
meruli [20]. The severity of the disease is further accentu-
ated by production of host anti-rabbit IgG antibody and
its subsequent implantation onto the GBM. The evolu-
tion of these lesions of crescentic glomerulonephritis can
be suppressed with the DEX treatment. The latter in-Fig. 7. In situ TUNEL assay of kidney tissues. (A) In NTS-treated
control rat, TUNEL-positive apoptotic cells can be seen in the glomeru- duced apoptosis in both CD41 and CD81 cells and abol-
lus (arrow; bar, 50 mm). (B) Administration of DEX and galectins ished the anti-rabbit IgG antibody production and thedid not alter the number of apoptotic cells present in the glomeruli.
Definitions of the groups are in the legend to Figure 3. influx of CD81 cells and macrophages into the glomeruli.
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Fig. 8. Apoptosis assay of T cells isolated from spleen. In DEX-treated normal rats, apoptosis was induced in approximately 25% of the CD41
cells and in approximately 28% of the CD81 cells. In DEX-treated NTS rats, a similar degree of apoptosis was seen in the CD41 (,20%) and
CD81 (,26%) cells. Although G9 did not induce apoptosis in CD41 and CD81 cells in normal rats, it did induce apoptosis in CD81 cells (,17%)
in NTS rats. Definitions of the groups are in the legend to Figure 3.
The apoptotic effect of DEX was dramatic, but it was cross-link the ligands and thereby to induce comparable
degree of apoptosis [16].not selective since it affected both the CD41 and CD81
Although G1 and G3 failed to inhibit apoptosis ofcells even in normal WKY rats. In contrast, G9 selec-
CD81 cells, influx of CD81 cells and the antibody pro-tively induced apoptosis of CD81 cells and reduced the
duction, it suppressed the macrophage infiltration, cres-infiltration of CD81 cells and of macrophages and ulti-
cent formation, and urinary excretion of proteins. Here,mately the formation of crescents. G1 was expected to
one may speculate that the therapeutic effect may beinduce apoptosis of activated T cells but did not do so.
mediated by several different mechanisms, includingThis differential apoptotic effect observed in our investi-
modulation of cell–cell or cell–matrix adhesion and pro-gation may be attributable to the difference in their struc-
liferation. G1 and G3 are known to mediate cell–cell or
tural characteristics. The G9, endowed with two carbohy- cell–matrix adhesive interactions; however, the findings
drate-binding domains in a single polypeptide chain, have not been consistent [3]. G1 promotes the adhesion
does not need to undergo dimerization in order to cross- of ovarian carcinoma cells to ECM [29], whereas it inhib-
link with the ligands and thus can induce apoptosis in its the adhesion of myoblast to laminin [30]. Similarly,
vitro at a relatively low concentration, that is, 1 mmol/L G3 mediates adhesion of the neutrophils [31], but not
[6]. On other hand, G1 induces a comparable degree of of the melanoma cells to laminin [32, 33]. The latter
apoptosis in vitro at a concentration of 7 mmol/L [16, 28]. binary action of G3 may be related to its concentration
and expression and to the glycosylation of the counter-Also, G1 needs to undergo homodimerization in order to
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Fig. 9. Distribution of intrinsic and exoge-
nously injected G9. Normal WKY rats were
injected with G9, which is the fusion protein
with N-terminal c-myc and (His)6 epitopes. In
kidney tissues, exogenous G9 was detected
with monoclonal anti-myc antibody and rho-
damine-labeled horse anti-mouse IgG (red).
Intrinsic G9 was detected with rabbit anti-G9
antibody [5, 6] and FITC-labeled donkey anti-
rabbit IgG (green). Exogenous G9 was de-
tected on glomerular endothelial cells and en-
dothelial cells of peritubular capillaries (red).
The immunoreactivity of intrinsic G9 was also
detected on glomerular cells, and it distributed
on endothelial cells and mesangial cells.
receptors [3]. Albeit these divergent actions, in general blasts [37]. Such biphasic response in cell growth seems
to be concentration dependent [38]. Thus, it is conceiv-galectins seem to cross-link glycoconjugates of different
cells or of cell and ECM to facilitate adhesion. However, able that the exogenous administration of galectins in-
hibited the macrophage infiltration in WKY rats, whichin the presence of the high concentration of galectins,
the cell surface glycoproteins on the same cells get cross- ultimately ameliorate the glomerular injuries.
Although G9 is normally expressed in glomeruli bothlinked, and the divalent carbohydrate-binding domains
on endothelial and mesangial cells [6], the administrationof galectins become occupied. As a result, they lose their
of large amounts of galectins unexpectedly inhibit theadhesive potential [33]. In any instance, the inhibitory
macrophage infiltration to the glomeruli. Since adminis-effect of G1 and G3 on the macrophage influx in NTS-
tered galectins dominantly distributed on glomerular en-nephritis as observed in WKY rats can be explained on
dothelial cells, the presence of higher concentration ofthe basis of their strategic expression within the glomeru-
galectins on the endothelial cells may alter the adhesive-lus and the circulating inflammatory cells. G1 is ex-
ness of the cells and may exert an inhibitory action. Thepressed in endothelial cells, and it is up-regulated by
unexpected suppression of macrophage infiltration intointerleukin-1, transforming growth factor-b, and inter-
the glomeruli suggests that such a pharmacological effectferon-g [34], while G3 is expressed in the monocytes and
may be common to all members of the galectin family,macrophages [35]. It can be speculated here that the
and another potential use of the galectins as therapeuticadministered exogenous galectins reduced the adhesive-
tools would be in their employment for the modulationness by cross-linking the glycoproteins expressed on the
of macrophage infiltration and proliferation in varioussame cell, that is, endothelium or macrophage, thus re-
diseases.ducing the residency of macrophages within the renal
glomerulus. Immunohistochemical detection of exoge-
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